Welcome to our dedicated page for Altisource Portfolio SEC filings (Ticker: ASPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Altisource Portfolio Solutions serves loan servicers, real-estate investors, and mortgage originators through two distinct segments. That breadth shows up in dense disclosures: segment revenue tables, servicing fee dynamics, regulatory examinations, and marketplace technology spend often span hundreds of pages. Investors searching for "Altisource Portfolio Solutions SEC filings explained simply" or trying to track "Altisource Portfolio Solutions insider trading Form 4 transactions" know the challenge of finding what matters. Stock Titan tackles this complexity by combining EDGAR speed with AI-generated context, turning every newly posted document into an accessible briefing.
Hunting for operating trends? Our dashboard links the "Altisource Portfolio Solutions quarterly earnings report 10-Q filing" to visual revenue bridges and margin shifts, while the "Altisource Portfolio Solutions annual report 10-K simplified" summary flags servicing concentration risk in plain English. Need event alerts? We translate each "Altisource Portfolio Solutions 8-K material events explained" in minutes and push mobile notifications for "Altisource Portfolio Solutions Form 4 insider transactions real-time". Whether you are monitoring "Altisource Portfolio Solutions executive stock transactions Form 4" ahead of dividends or comparing segments, the platform keeps you current without manual digging.
Because governance details drive valuation, analysts also rely on our annotated view of the "Altisource Portfolio Solutions proxy statement executive compensation" to spot incentive structures tied to foreclosure volumes. Interactive filters support "Altisource Portfolio Solutions earnings report filing analysis" across multiple quarters, and the "understanding Altisource Portfolio Solutions SEC documents with AI" guide explains how our language models extract field-service backlog, origination pipeline metrics, and compliance costs. From real-time filings to evergreen insight, Stock Titan delivers every disclosure, summarized, searchable, and ready for decisive action.
Akero Therapeutics, Inc. (AKRO) Form 4 filing: Chief Scientific Officer Timothy Rolph reported option exercise and related share sales on 07/07/2025 under a Rule 10b5-1 trading plan adopted 08/12/2024.
- Option exercise (Code M): Rolph exercised 12,500 options at an exercise price of $21.09, converting them into an equal number of common shares.
- Open-market sales: Immediately after exercise he sold the same 12,500 shares in three tranches: 10,634 sh at a weighted-average $50.932, 1,825 sh at $51.996, and 41 sh at $52.617.
- Net ownership: Shares directly held decreased from 179,624 to 167,124 (-7.0%). Derivative holdings stand at 19,933 vested, unexercised options (exercise price $21.09, expiring 12/12/2029).
The transaction yielded roughly $640k in gross proceeds while leaving Rolph with a substantial equity position. Because the exercise and sale amounts offset, cash was realized but the company鈥檚 share count is unchanged. The filing does not disclose motive beyond the pre-arranged trading plan and contains no operational or earnings information.
Akero Therapeutics, Inc. (AKRO) Form 4 filing: Chief Scientific Officer Timothy Rolph reported option exercise and related share sales on 07/07/2025 under a Rule 10b5-1 trading plan adopted 08/12/2024.
- Option exercise (Code M): Rolph exercised 12,500 options at an exercise price of $21.09, converting them into an equal number of common shares.
- Open-market sales: Immediately after exercise he sold the same 12,500 shares in three tranches: 10,634 sh at a weighted-average $50.932, 1,825 sh at $51.996, and 41 sh at $52.617.
- Net ownership: Shares directly held decreased from 179,624 to 167,124 (-7.0%). Derivative holdings stand at 19,933 vested, unexercised options (exercise price $21.09, expiring 12/12/2029).
The transaction yielded roughly $640k in gross proceeds while leaving Rolph with a substantial equity position. Because the exercise and sale amounts offset, cash was realized but the company鈥檚 share count is unchanged. The filing does not disclose motive beyond the pre-arranged trading plan and contains no operational or earnings information.
FAQ
What is the current stock price of Altisource Portfolio (ASPS)?
What is the market cap of Altisource Portfolio (ASPS)?
What are the primary business segments of Altisource Portfolio Solutions SA?
What services does the Servicer and AG真人官方 Estate segment provide?
How does the Origination segment support mortgage originators?
Who are the primary customers of Altisource Portfolio Solutions SA?
What role does technology play in Altisource's business model?
How does Altisource differentiate itself in the real estate and mortgage markets?
What are some key industry terms associated with Altisource Portfolio Solutions SA?
How is the information about Altisource organized for investor research?
